Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06132581 · ClinicalTrials.gov registry record · NA
Causal Role of Delta-beta Coupling for Goal-directed Behavior in Anhedonic Depression
A NA study of Major Depressive Disorder and Anhedonia, sponsored by Florida State University.
- Recruiting
- Registry status
- NA
- Development phase
- 72
- Enrollment target
- 1
- Study location
NCT06132581 is a NA study of Major Depressive Disorder and Anhedonia that is actively recruiting participants, run by Florida State University. The registered enrollment target is 72 participants, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06132581, a NA study of Major Depressive Disorder and Anhedonia, is actively recruiting participants, sponsored by Florida State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
- 1
- Study location
Study Summary
Anhedonia, the inability to seek-out and experience pleasure, is a common symptom in depression that predicts treatment-resistance and is sometimes exacerbated by first-line antidepressants. In our previous research, we found that anhedonia decreases goal-directed behavior and its related neural activity. In this study, we will investigate target engagement from five-consecutive days of stimulation for participants that are within a unipolar major depressive episode and also have high symptoms of anhedonia.
Conditions Studied
Interventions
- DEVICE Delta-beta tACS via the Neurocare Direct Current Stimulator Multi-Channel 4
- DEVICE Theta-gamma tACS via the Neurocare Direct Current Stimulator Multi-Channel 4
- DEVICE Sham tACS via the Neurocare Direct Current Stimulator Multi-Channel 4
Study Locations (1)
Florida
- Florida State University - Tallahassee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2024-01-24 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06132581
The ClinicalTrials.gov registry entry for NCT06132581 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (81% lower). The listed sponsor is Florida State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Major Depressive Disorder appearing as the primary indexed condition, and to 3 interventions - of which Delta-beta tACS via the Neurocare Direct Current Stimulator Multi-Channel 4 is the first listed.
NCT06132581 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06132581 about?
NCT06132581 is a clinical study titled "Causal Role of Delta-beta Coupling for Goal-directed Behavior in Anhedonic Depression". Anhedonia, the inability to seek-out and experience pleasure, is a common symptom in depression that predicts treatment-resistance and is sometimes exacerbated by first-line antidepressants. In our previous research, we found that anhedonia decreases goal-directed behavior and its related neural act...
What is the current status of trial NCT06132581?
This trial is currently recruiting. It is a NA study. The enrollment target is 72 participants. The study started on 2024-01-24. Estimated completion is 2026-07-31.
What conditions does trial NCT06132581 study?
This clinical trial studies the following conditions: Major Depressive Disorder, Anhedonia.
What interventions are being tested in trial NCT06132581?
The interventions under investigation include: Delta-beta tACS via the Neurocare Direct Current Stimulator Multi-Channel 4 (DEVICE), Theta-gamma tACS via the Neurocare Direct Current Stimulator Multi-Channel 4 (DEVICE), Sham tACS via the Neurocare Direct Current Stimulator Multi-Channel 4 (DEVICE).
Who is sponsoring clinical trial NCT06132581?
This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06132581 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Major Depressive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Taking Action for College Students
RECRUITING · NA
-
Targeting Large-scale Networks in Depression With Real-time Functional Magnetic Resonance Imaging (fMRI) Neurofeedback
RECRUITING · NA
-
Neural Correlates of Stress and Perceived Control in Adolescent Depression
RECRUITING · NA
-
Positive Processes and Transition to Health (PATH)
RECRUITING · NA
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Amygdala Neurofeedback for Depression - Large Scale Clinical Trial
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.